Prudential PLC Purchases 10,568 Shares of The Cooper Companies, Inc. $COO

Prudential PLC lifted its position in The Cooper Companies, Inc. (NASDAQ:COO) by 16.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 74,579 shares of the medical device company’s stock after acquiring an additional 10,568 shares during the quarter. Prudential PLC’s holdings in Cooper Companies were worth $5,307,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in COO. Horizon Investments LLC increased its position in Cooper Companies by 5.0% during the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company’s stock valued at $241,000 after purchasing an additional 136 shares during the period. Wealth Alliance LLC lifted its position in shares of Cooper Companies by 4.2% in the 2nd quarter. Wealth Alliance LLC now owns 4,230 shares of the medical device company’s stock worth $301,000 after purchasing an additional 171 shares during the period. State of Michigan Retirement System boosted its stake in shares of Cooper Companies by 0.4% during the second quarter. State of Michigan Retirement System now owns 54,344 shares of the medical device company’s stock valued at $3,867,000 after purchasing an additional 200 shares in the last quarter. New York Life Investment Management LLC boosted its stake in shares of Cooper Companies by 0.7% during the second quarter. New York Life Investment Management LLC now owns 30,019 shares of the medical device company’s stock valued at $2,136,000 after purchasing an additional 210 shares in the last quarter. Finally, EverSource Wealth Advisors LLC increased its holdings in Cooper Companies by 3.5% during the first quarter. EverSource Wealth Advisors LLC now owns 6,517 shares of the medical device company’s stock valued at $550,000 after buying an additional 220 shares during the period. 24.39% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have weighed in on COO shares. Piper Sandler lowered their target price on Cooper Companies from $105.00 to $83.00 and set an “overweight” rating for the company in a report on Thursday, August 28th. Needham & Company LLC restated a “buy” rating and set a $94.00 price objective on shares of Cooper Companies in a research note on Thursday, August 28th. Morgan Stanley set a $76.00 price objective on Cooper Companies and gave the company an “equal weight” rating in a research report on Thursday, August 28th. Robert W. Baird reduced their target price on shares of Cooper Companies from $97.00 to $85.00 and set an “outperform” rating for the company in a report on Thursday, August 28th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Cooper Companies from $76.00 to $66.00 and set a “neutral” rating for the company in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $84.77.

Insider Buying and Selling

In other news, CEO Albert G. White III purchased 10,000 shares of the stock in a transaction dated Friday, September 5th. The shares were purchased at an average cost of $68.39 per share, with a total value of $683,900.00. Following the completion of the purchase, the chief executive officer directly owned 226,151 shares of the company’s stock, valued at approximately $15,466,466.89. The trade was a 4.63% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Lawrence Erik Kurzius acquired 2,000 shares of Cooper Companies stock in a transaction that occurred on Monday, September 29th. The stock was purchased at an average cost of $68.39 per share, with a total value of $136,780.00. Following the completion of the purchase, the director owned 5,777 shares in the company, valued at $395,089.03. The trade was a 52.95% increase in their position. The SEC filing for this purchase provides additional information. Insiders acquired a total of 17,975 shares of company stock worth $1,216,346 in the last quarter. 1.98% of the stock is owned by insiders.

Cooper Companies Stock Up 6.1%

Cooper Companies stock opened at $75.47 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $106.63. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The company has a market cap of $15.00 billion, a PE ratio of 37.18, a PEG ratio of 1.83 and a beta of 1.02. The business’s 50-day simple moving average is $70.15 and its two-hundred day simple moving average is $72.04.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping analysts’ consensus estimates of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The company’s revenue was up 5.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies declared that its board has authorized a stock buyback program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the medical device company to repurchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company’s management believes its stock is undervalued.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.